The role of the inflammatory microenvironment in Acellular Nerve Allografts (ANAs) repairing nerve gaps
炎症微环境在无细胞神经同种异体移植物(ANA)修复神经间隙中的作用
基本信息
- 批准号:10678384
- 负责人:
- 金额:$ 3.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAllogenicAllograftingAutologous TransplantationAxonBiomedical EngineeringBlood VesselsCaringCellsChemicalsChronicClinicClinicalDataDefectDetergentsExpenditureExtracellular MatrixFK506FellowshipGene ExpressionGoalsHarvestImmunologyImmunosuppressive AgentsInflammationInflammatoryInflammatory ResponseInjuryInterventionKnowledgeLearningLengthMacrophageMeasuresModelingModificationMolecular TargetMorbidity - disease rateMorphologyNatural regenerationNerveNerve RegenerationNeurobiologyOperative Surgical ProceduresPatientsPeripheral NervesPeripheral nerve injuryProcessQuality of lifeRattusRecovery of FunctionResearchRoleScientistSiteT-LymphocyteTacrolimusTechniquesTestingTimeTrainingTranslatingTraumaUnited Statesangiogenesisaxon regenerationcell motilitycytokineexperienceimmunogenicityinflammatory markerinflammatory milieuinflammatory modulationmigrationmyelinationnerve autograftnerve damagenerve gapnerve injurynerve repairnovelpharmacologicreconstructionregeneration potentialregenerativerepairedsciatic nervesingle-cell RNA sequencingstandard of caretherapy development
项目摘要
PROJECT SUMMARY/ABSTRACT
Reconstruction of peripheral nerve gap injuries continues to pose a challenge in the clinic due to their
significant long-term functional morbidity. Multiple surgical approaches have been developed to promote
nerve regeneration across a damaged nerve with a gap. In the clinic, nerve autografts are considered the
standard of care in treating nerve gaps due to their superior capacity in promoting nerve regeneration.
However, the use of nerve autografts is limited by their availability, increased surgery time, loss of nerve
function from the lost nerve and donor site morbidity. Acellular nerve allografts (ANAs) have been proposed
as a clinical alternative to autografts in repairing nerve gaps due to their capability in promoting regeneration
across short gaps (< 3 cm). ANAs are allogenic nerves that are chemically processed to remove the cells,
reducing immunogenicity, while maintaining the extracellular matrix (ECM) that will allow cell migration into
the ANA and subsequent nerve regeneration. However, unlike autografts, ANAs do not support regeneration
across long defects (> 3 cm). The reason why long ANAs do not promote regeneration or regenerate poorly
is not completely understood. Previous studies have demonstrated the critical role of inflammatory cells,
such as macrophages and T cells, in regulating and promoting the early stages of nerve regeneration in
ANAs (before 4 weeks post-surgery). Specifically, macrophages will promote angiogenesis and T cells will
promote axonal myelination. However, when compared to short ANAs capable of robust regeneration,
preliminary data shows an increase in the expression of pro-inflammatory cytokines and changes in the
morphology of blood vessels in long ANAs at the later stages of nerve regeneration (between 4- and 8-
weeks post-surgery). The increase in the expression of pro-inflammatory cytokines and the changes in the
morphology of blood vessels happen after angiogenesis has occurred and axons have started migrating into
the ANAs. These changes suggest that a pro-inflammatory environment develops inside long ANAs in the
later stages of nerve regeneration, and this correlates with changes in the morphology of blood vessels and
a decrease in the number of myelinated axons. We hypothesize the state of chronic inflammation in long
ANAs is disrupting the regenerative microenvironment in long ANAs. In brief, the proposed research aims
to characterize and compare the inflammatory microenvironment that develops in the later stages of nerve
regeneration in long ANAs with the microenvironment in the regenerated short ANAs and autografts. This
project also explores the effect of reducing inflammation in long ANAs, using a pharmacological intervention,
on axonal regeneration. An integral part of this study is to identify the cell subpopulations promoting the pro-
inflammatory microenvironment in long ANAs. An in-depth analysis of these cell subpopulations may provide
specific molecular targets used to develop therapies aimed to promote nerve regeneration in long ANAs.
项目概要/摘要
周围神经间隙损伤的重建仍然在临床上构成挑战,因为它们
显着的长期功能发病率。已开发出多种手术方法来促进
神经再生穿过有间隙的受损神经。在临床上,自体神经移植被认为是
由于其促进神经再生的卓越能力,因此成为治疗神经间隙的护理标准。
然而,自体神经移植的使用受到其可用性、手术时间增加、神经损失的限制。
神经功能丧失和供体部位发病率。已提出脱细胞神经同种异体移植物(ANA)
由于其具有促进再生的能力,可作为自体移植物修复神经间隙的临床替代方案
穿过短间隙 (< 3 cm)。 ANA 是同种异体神经,经过化学处理以去除细胞,
降低免疫原性,同时维持细胞外基质 (ECM),使细胞能够迁移到
ANA 和随后的神经再生。然而,与自体移植不同,ANA 不支持再生
跨越长缺陷 (> 3 cm)。长 ANA 不促进再生或再生不良的原因
还没有完全理解。先前的研究已经证明炎症细胞的关键作用,
例如巨噬细胞和T细胞,在调节和促进神经再生的早期阶段
ANA(术后 4 周前)。具体来说,巨噬细胞将促进血管生成,T细胞将
促进轴突髓鞘形成。然而,与能够稳健再生的短 ANA 相比,
初步数据显示促炎细胞因子的表达增加以及
神经再生后期(4-和8-之间)长ANA中的血管形态
手术后几周)。促炎细胞因子表达的增加和
血管的形态发生在血管生成发生并且轴突开始迁移到
ANA。这些变化表明促炎环境在长 ANA 内形成
神经再生的后期阶段,这与血管和血管形态的变化相关
有髓轴突数量减少。我们假设长期慢性炎症状态
ANA 正在破坏长 ANA 中的再生微环境。简而言之,拟议的研究目标
表征和比较神经后期发展的炎症微环境
长 ANA 的再生与再生短 ANA 和自体移植物中的微环境的关系。这
项目还探索了使用药物干预来减少长 ANA 炎症的效果,
关于轴突再生。这项研究的一个组成部分是确定促进亲细胞亚群的细胞亚群。
长 ANA 中的炎症微环境。对这些细胞亚群的深入分析可以提供
用于开发旨在促进长 ANA 神经再生的疗法的特定分子靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jesús Alberto Acevedo Cintrón其他文献
Jesús Alberto Acevedo Cintrón的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
- 批准号:
10039902 - 财政年份:2022
- 资助金额:
$ 3.36万 - 项目类别:
EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
- 批准号:
21K15925 - 财政年份:2021
- 资助金额:
$ 3.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
- 批准号:
21K08410 - 财政年份:2021
- 资助金额:
$ 3.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
- 批准号:
20K21672 - 财政年份:2020
- 资助金额:
$ 3.36万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
- 批准号:
18K16395 - 财政年份:2018
- 资助金额:
$ 3.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
- 批准号:
17K10951 - 财政年份:2017
- 资助金额:
$ 3.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
- 批准号:
370541 - 财政年份:2017
- 资助金额:
$ 3.36万 - 项目类别:
Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
- 批准号:
16K10863 - 财政年份:2016
- 资助金额:
$ 3.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
- 批准号:
276706135 - 财政年份:2015
- 资助金额:
$ 3.36万 - 项目类别:
Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
- 批准号:
15H04915 - 财政年份:2015
- 资助金额:
$ 3.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




